Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Neefe

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Seminars in Oncology|October 1, 1991
Mechanisms of interaction of interferon and 5-fluorouracil in solid tumorsJ R Neefe, W John
Cancer Research|June 15, 1991
Abrogation of interferon-induced resistance to interferon-activated major histocompatibility complex-unrestricted killers by treatment of a melanoma cell line with 5-fluorouracilJ R Neefe, J Glass
The Journal of Experimental Medicine|October 1, 1976
Specific elimination of cytotoxic effector cells. I. Adsorptive behavior of effectors and their precursors and spleen cell monolayersJ R Neefe, D H Sachs
Cancer Chemotherapy and Pharmacology|January 1, 1986
Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomesA Rahman, A Ganjei, J R Neefe
British Journal of Cancer|September 1, 1986
Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomesA Rahman, A Joher, J R Neefe
Diagnostic Immunology|January 1, 1986
Augmentation of natural immunity and correlation with tumor response in melanoma patients treated with human lymphoblastoid interferonJ R Neefe, E A Phillips, J Treat
Journal of Biological Response Modifiers|January 1, 1983
Preliminary observations of immunomodulatory activity of lymphoblastoid interferon-alpha administered every other day or weeklyJ R Neefe, J E Sullivan, R Silgals
Developments in Biologicals|December 18, 2004
CoVal fusions: a therapeutic vaccine platform using heat shock proteins to treat chronic viral infection and cancerJ R Neefe, N R Chu, L Mizzen
Transplantation|August 1, 1979
Genetic analysis of 23 RhL-A histocompatibility antigens of the rhesus monkeyB A Maurer, J Jones, J R Neefe
Tissue Antigens|February 1, 1979
Definition of two LD antigens in rhesus monkeysB A Maurer, D F Siwarski, J R Neefe
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Seminars in Oncology|October 1, 1991
Mechanisms of interaction of interferon and 5-fluorouracil in solid tumorsJ R Neefe, W John
Cancer Research|June 15, 1991
Abrogation of interferon-induced resistance to interferon-activated major histocompatibility complex-unrestricted killers by treatment of a melanoma cell line with 5-fluorouracilJ R Neefe, J Glass
The Journal of Experimental Medicine|October 1, 1976
Specific elimination of cytotoxic effector cells. I. Adsorptive behavior of effectors and their precursors and spleen cell monolayersJ R Neefe, D H Sachs
Cancer Chemotherapy and Pharmacology|January 1, 1986
Comparative immunotoxicity of free doxorubicin and doxorubicin encapsulated in cardiolipin liposomesA Rahman, A Ganjei, J R Neefe
British Journal of Cancer|September 1, 1986
Immunotoxicity of multiple dosing regimens of free doxorubicin and doxorubicin entrapped in cardiolipin liposomesA Rahman, A Joher, J R Neefe
Diagnostic Immunology|January 1, 1986
Augmentation of natural immunity and correlation with tumor response in melanoma patients treated with human lymphoblastoid interferonJ R Neefe, E A Phillips, J Treat
Journal of Biological Response Modifiers|January 1, 1983
Preliminary observations of immunomodulatory activity of lymphoblastoid interferon-alpha administered every other day or weeklyJ R Neefe, J E Sullivan, R Silgals
Developments in Biologicals|December 18, 2004
CoVal fusions: a therapeutic vaccine platform using heat shock proteins to treat chronic viral infection and cancerJ R Neefe, N R Chu, L Mizzen
Transplantation|August 1, 1979
Genetic analysis of 23 RhL-A histocompatibility antigens of the rhesus monkeyB A Maurer, J Jones, J R Neefe
Tissue Antigens|February 1, 1979
Definition of two LD antigens in rhesus monkeysB A Maurer, D F Siwarski, J R Neefe
Pageof 4